Average Co-Inventor Count = 4.68
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (20 from 3,923 patents)
2. Novartis Pharma Gmbh (8 patents)
20 patents:
1. 10683287 - Heterocyclic derivatives and their use in the treatment of neurological disorders
2. 10301296 - Heterocyclic derivatives and their use in the treatment of neurological disorders
3. 10202371 - Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors
4. 10035794 - Heterocyclic derivatives and their use in the treatment of neurological disorders
5. 9890166 - Imidazopyrrolidine derivatives and their use in the treatment of disease
6. 9714249 - Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease
7. 9624247 - Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease
8. 9550758 - Heterocyclic derivatives and their use in the treatment of neurological disorders
9. 9458177 - Oxazolidin-2-one compounds and uses thereof
10. 9296733 - Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
11. 9284284 - Oxazine derivatives and their use in the treatment of disease
12. 9163011 - Oxazine derivatives and their use in the treatment of disease
13. 8975417 - Pyrazolopyrrolidine derivatives and their use in the treatment of disease
14. 8865712 - Heterocyclic derivatives and their use in the treatment of neurological disorders
15. 8865894 - Oxazolidin-2-one compounds and uses thereof